Ex-vivo red blood cells generation: a step ahead in transfusion medicine?

[1]  S. Viville,et al.  Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine , 2010, Haematologica.

[2]  D. Anstee.  Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS). , 2010, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[3]  G. Lippi,et al.  Recombinants in thrombosis and hemostasis: from basic research to clinical therapy. , 2010, Seminars in thrombosis and hemostasis.

[4]  M. Turner,et al.  Prospects for the manufacture of red cells for transfusion , 2010, British journal of haematology.

[5]  T. Frietsch,et al.  [Artificial blood - coming soon or never reaching clinical maturity?]. , 2010, Deutsche medizinische Wochenschrift.

[6]  G. Lippi,et al.  Red blood cell-mimicking synthetic biomaterial particles: the new frontier of blood doping? , 2010, International journal of sports medicine.

[7]  H. Baharvand,et al.  Generation of human induced pluripotent stem cells from a Bombay individual: moving towards "universal-donor" red blood cells. , 2010, Biochemical and biophysical research communications.

[8]  Samir Mitragotri,et al.  Red blood cell-mimicking synthetic biomaterial particles , 2009, Proceedings of the National Academy of Sciences.

[9]  G. Liumbruno,et al.  Recommendations for the transfusion of red blood cells. , 2009, Blood transfusion = Trasfusione del sangue.

[10]  Qiang Feng,et al.  Biologic properties and enucleation of red blood cells from human embryonic stem cells. , 2008, Blood.

[11]  H. Nakauchi,et al.  Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis , 2008, Proceedings of the National Academy of Sciences.

[12]  C. Ware,et al.  Blood types of current embryonic stem cell lines are not conducive to culturing “universal‐donor” red blood cells , 2008, Transfusion.

[13]  Yukio Nakamura,et al.  Establishment of Mouse Embryonic Stem Cell-Derived Erythroid Progenitor Cell Lines Able to Produce Functional Red Blood Cells , 2008, PloS one.

[14]  A. Greenburg,et al.  Toward 21st Century Blood Component Replacement Therapeutics: Artificial Oxygen Carriers, Platelet Substitutes, Recombinant Clotting Factors, and Others , 2006, Artificial cells, blood substitutes, and immobilization biotechnology.

[15]  G. Lippi,et al.  Biochemistry, Physiology, and Complications of Blood Doping: Facts and Speculation , 2006, Critical reviews in clinical laboratory sciences.

[16]  J. Duguid,et al.  Guidelines for the clinical use of red cell transfusions , 2001, British journal of haematology.

[17]  J D Milam,et al.  Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. , 1998, Archives of pathology & laboratory medicine.

[18]  B. Larke,et al.  Guidelines for red blood cell and plasma transfusion for adults and children. , 1997, The International journal of risk & safety in medicine.

[19]  P. Gunter.  Practice Guidelines for Blood Component Therapy , 1996 .

[20]  Andrew D. Rosenberg,et al.  Practice Guidelines for Blood Component Therapy: A Report by the American Society of Anesthesiologists Task Force on Blood Component Therapy , 1996, Anesthesiology.